2Seventy Bio Inc expected to post a loss of $1.03 a share - Earnings Preview

2Seventy Bio

03/11/2023 12:19

* 2Seventy Bio Inc  TSVT.OQ   TSVT.O  is expected to show a
rise
in quarterly revenue when it reports  results 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 132.5% increase in revenue to $31.177 million from $13.41
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for 2Seventy Bio Inc is
for a
loss of $1.03 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for 2Seventy
Bio Inc
is $10​, above​ its last closing price of $2.32. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -1.09       -1.06      -0.83     Beat    22.1
 Mar. 31 2023  -1.20       -1.19      -1.08     Beat    9.5
 Dec. 31 2022  -1.59       -1.61      -0.60     Beat    62.6​
 Sep. 30 2022  -1.86       -1.80      -1.76     Beat    2.5
 ​​Jun.        -2.24       -2.28      -2.02     Beat    11.2
 30 2022                                                
 Mar. 31 2022  -1.84       -2.05      -3.20     Missed  -56​
 Dec. 31 2021  -2.68       -2.84      -2.55     Beat    10.1
 Sep. 30 2021  -2.71       -2.71      -2.62     Beat    3.3
 This summary was machine generated November 3 at 12:19 GMT.  All
figures in US dollars  unless otherwise stated